ARCHIVES

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

Construction Needs From NCI Said $40 Million Year For Four Years

June 9, 1978

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998